Pregnancy and melanoma
Malignant melanoma is the most common malignancy during pregnancy, and is diagnosed during childbearing age in approximately one-third of women diagnosed with melanoma. The impact of hormonal changes during pregnancy and from iatrogenic hormones on melanoma is controversial. Women undergo immunologi...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2016-10, Vol.75 (4), p.669-678 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 678 |
|---|---|
| container_issue | 4 |
| container_start_page | 669 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 75 |
| creator | Driscoll, Marcia S., MD, PharmD Martires, Kathryn, MD Bieber, Amy Kalowitz, BS Pomeranz, Miriam Keltz, MD Grant-Kels, Jane M., MD Stein, Jennifer A., MD, PhD |
| description | Malignant melanoma is the most common malignancy during pregnancy, and is diagnosed during childbearing age in approximately one-third of women diagnosed with melanoma. The impact of hormonal changes during pregnancy and from iatrogenic hormones on melanoma is controversial. Women undergo immunologic changes during pregnancy that may decrease tumor surveillance. In addition, hormone receptors are found on some melanomas. In spite of these observations, the preponderance of evidence does not support a poorer prognosis for pregnancy-associated melanomas. There is also a lack of evidence that oral contraceptives or hormone replacement therapy worsens melanoma prognosis. |
| doi_str_mv | 10.1016/j.jaad.2016.01.061 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1822118775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962216300391</els_id><sourcerecordid>1822118775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-ed4cb051746a55c1bf305a775528ecfd1f49964f71e26e1e61519ac27e7014a13</originalsourceid><addsrcrecordid>eNp9kc1Lw0AQxRdRbK1ePXiQHr0kzmw2uw2IIMUvKCio52W7mUhiPupuI_S_d0OrBw-eZg7vPWZ-j7EzhBgB5WUVV8bkMQ97DBiDxD02RshUJNVM7bMxYAZRJjkfsSPvKwDIRKIO2YgrKaRK1JidPjt6b01rN1PT5tOGatN2jTlmB4WpPZ3s5oS93d2-zh-ixdP94_xmEVmBuI4oF3YJKSohTZpaXBYJpEapNOUzskWOhcgyKQqFxCUhSUwxM5YrUoDCYDJhF9vcles-e_Jr3ZTeUh2uoK73GmecI85CYpDyrdS6zntHhV65sjFuoxH0wENXeuChBx4aUAcewXS-y--XDeW_lh8AQXC1FVD48qskp70tqbWUl47sWudd-X_-9R-7rcu2tKb-oA35qutdG_hp1J5r0C9DI0MhKBOAJMPkG_8EguQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1822118775</pqid></control><display><type>article</type><title>Pregnancy and melanoma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Driscoll, Marcia S., MD, PharmD ; Martires, Kathryn, MD ; Bieber, Amy Kalowitz, BS ; Pomeranz, Miriam Keltz, MD ; Grant-Kels, Jane M., MD ; Stein, Jennifer A., MD, PhD</creator><creatorcontrib>Driscoll, Marcia S., MD, PharmD ; Martires, Kathryn, MD ; Bieber, Amy Kalowitz, BS ; Pomeranz, Miriam Keltz, MD ; Grant-Kels, Jane M., MD ; Stein, Jennifer A., MD, PhD</creatorcontrib><description>Malignant melanoma is the most common malignancy during pregnancy, and is diagnosed during childbearing age in approximately one-third of women diagnosed with melanoma. The impact of hormonal changes during pregnancy and from iatrogenic hormones on melanoma is controversial. Women undergo immunologic changes during pregnancy that may decrease tumor surveillance. In addition, hormone receptors are found on some melanomas. In spite of these observations, the preponderance of evidence does not support a poorer prognosis for pregnancy-associated melanomas. There is also a lack of evidence that oral contraceptives or hormone replacement therapy worsens melanoma prognosis.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2016.01.061</identifier><identifier>PMID: 27646737</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biopsy, Needle ; Dermatology ; Female ; hormone replacement therapy ; Humans ; Immunohistochemistry ; Incidence ; melanoma ; Melanoma - diagnosis ; Melanoma - epidemiology ; Melanoma - therapy ; Melanoma, Cutaneous Malignant ; Monitoring, Physiologic - methods ; Neoplasm Invasiveness - pathology ; Neoplasm Staging ; oral contraceptives ; Postpartum Period ; Pregnancy ; Pregnancy Complications, Neoplastic - diagnosis ; Pregnancy Complications, Neoplastic - epidemiology ; Pregnancy Complications, Neoplastic - therapy ; Pregnancy Outcome ; Prenatal Diagnosis ; Prognosis ; review ; Risk Assessment ; Skin Neoplasms - diagnosis ; Skin Neoplasms - epidemiology ; Skin Neoplasms - therapy</subject><ispartof>Journal of the American Academy of Dermatology, 2016-10, Vol.75 (4), p.669-678</ispartof><rights>American Academy of Dermatology, Inc.</rights><rights>2016 American Academy of Dermatology, Inc.</rights><rights>Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-ed4cb051746a55c1bf305a775528ecfd1f49964f71e26e1e61519ac27e7014a13</citedby><cites>FETCH-LOGICAL-c411t-ed4cb051746a55c1bf305a775528ecfd1f49964f71e26e1e61519ac27e7014a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962216300391$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27646737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Driscoll, Marcia S., MD, PharmD</creatorcontrib><creatorcontrib>Martires, Kathryn, MD</creatorcontrib><creatorcontrib>Bieber, Amy Kalowitz, BS</creatorcontrib><creatorcontrib>Pomeranz, Miriam Keltz, MD</creatorcontrib><creatorcontrib>Grant-Kels, Jane M., MD</creatorcontrib><creatorcontrib>Stein, Jennifer A., MD, PhD</creatorcontrib><title>Pregnancy and melanoma</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Malignant melanoma is the most common malignancy during pregnancy, and is diagnosed during childbearing age in approximately one-third of women diagnosed with melanoma. The impact of hormonal changes during pregnancy and from iatrogenic hormones on melanoma is controversial. Women undergo immunologic changes during pregnancy that may decrease tumor surveillance. In addition, hormone receptors are found on some melanomas. In spite of these observations, the preponderance of evidence does not support a poorer prognosis for pregnancy-associated melanomas. There is also a lack of evidence that oral contraceptives or hormone replacement therapy worsens melanoma prognosis.</description><subject>Biopsy, Needle</subject><subject>Dermatology</subject><subject>Female</subject><subject>hormone replacement therapy</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Incidence</subject><subject>melanoma</subject><subject>Melanoma - diagnosis</subject><subject>Melanoma - epidemiology</subject><subject>Melanoma - therapy</subject><subject>Melanoma, Cutaneous Malignant</subject><subject>Monitoring, Physiologic - methods</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Staging</subject><subject>oral contraceptives</subject><subject>Postpartum Period</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Neoplastic - diagnosis</subject><subject>Pregnancy Complications, Neoplastic - epidemiology</subject><subject>Pregnancy Complications, Neoplastic - therapy</subject><subject>Pregnancy Outcome</subject><subject>Prenatal Diagnosis</subject><subject>Prognosis</subject><subject>review</subject><subject>Risk Assessment</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Skin Neoplasms - therapy</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1Lw0AQxRdRbK1ePXiQHr0kzmw2uw2IIMUvKCio52W7mUhiPupuI_S_d0OrBw-eZg7vPWZ-j7EzhBgB5WUVV8bkMQ97DBiDxD02RshUJNVM7bMxYAZRJjkfsSPvKwDIRKIO2YgrKaRK1JidPjt6b01rN1PT5tOGatN2jTlmB4WpPZ3s5oS93d2-zh-ixdP94_xmEVmBuI4oF3YJKSohTZpaXBYJpEapNOUzskWOhcgyKQqFxCUhSUwxM5YrUoDCYDJhF9vcles-e_Jr3ZTeUh2uoK73GmecI85CYpDyrdS6zntHhV65sjFuoxH0wENXeuChBx4aUAcewXS-y--XDeW_lh8AQXC1FVD48qskp70tqbWUl47sWudd-X_-9R-7rcu2tKb-oA35qutdG_hp1J5r0C9DI0MhKBOAJMPkG_8EguQ</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Driscoll, Marcia S., MD, PharmD</creator><creator>Martires, Kathryn, MD</creator><creator>Bieber, Amy Kalowitz, BS</creator><creator>Pomeranz, Miriam Keltz, MD</creator><creator>Grant-Kels, Jane M., MD</creator><creator>Stein, Jennifer A., MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161001</creationdate><title>Pregnancy and melanoma</title><author>Driscoll, Marcia S., MD, PharmD ; Martires, Kathryn, MD ; Bieber, Amy Kalowitz, BS ; Pomeranz, Miriam Keltz, MD ; Grant-Kels, Jane M., MD ; Stein, Jennifer A., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-ed4cb051746a55c1bf305a775528ecfd1f49964f71e26e1e61519ac27e7014a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biopsy, Needle</topic><topic>Dermatology</topic><topic>Female</topic><topic>hormone replacement therapy</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Incidence</topic><topic>melanoma</topic><topic>Melanoma - diagnosis</topic><topic>Melanoma - epidemiology</topic><topic>Melanoma - therapy</topic><topic>Melanoma, Cutaneous Malignant</topic><topic>Monitoring, Physiologic - methods</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Staging</topic><topic>oral contraceptives</topic><topic>Postpartum Period</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Neoplastic - diagnosis</topic><topic>Pregnancy Complications, Neoplastic - epidemiology</topic><topic>Pregnancy Complications, Neoplastic - therapy</topic><topic>Pregnancy Outcome</topic><topic>Prenatal Diagnosis</topic><topic>Prognosis</topic><topic>review</topic><topic>Risk Assessment</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Skin Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Driscoll, Marcia S., MD, PharmD</creatorcontrib><creatorcontrib>Martires, Kathryn, MD</creatorcontrib><creatorcontrib>Bieber, Amy Kalowitz, BS</creatorcontrib><creatorcontrib>Pomeranz, Miriam Keltz, MD</creatorcontrib><creatorcontrib>Grant-Kels, Jane M., MD</creatorcontrib><creatorcontrib>Stein, Jennifer A., MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Driscoll, Marcia S., MD, PharmD</au><au>Martires, Kathryn, MD</au><au>Bieber, Amy Kalowitz, BS</au><au>Pomeranz, Miriam Keltz, MD</au><au>Grant-Kels, Jane M., MD</au><au>Stein, Jennifer A., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pregnancy and melanoma</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>75</volume><issue>4</issue><spage>669</spage><epage>678</epage><pages>669-678</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><abstract>Malignant melanoma is the most common malignancy during pregnancy, and is diagnosed during childbearing age in approximately one-third of women diagnosed with melanoma. The impact of hormonal changes during pregnancy and from iatrogenic hormones on melanoma is controversial. Women undergo immunologic changes during pregnancy that may decrease tumor surveillance. In addition, hormone receptors are found on some melanomas. In spite of these observations, the preponderance of evidence does not support a poorer prognosis for pregnancy-associated melanomas. There is also a lack of evidence that oral contraceptives or hormone replacement therapy worsens melanoma prognosis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27646737</pmid><doi>10.1016/j.jaad.2016.01.061</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0190-9622 |
| ispartof | Journal of the American Academy of Dermatology, 2016-10, Vol.75 (4), p.669-678 |
| issn | 0190-9622 1097-6787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1822118775 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Biopsy, Needle Dermatology Female hormone replacement therapy Humans Immunohistochemistry Incidence melanoma Melanoma - diagnosis Melanoma - epidemiology Melanoma - therapy Melanoma, Cutaneous Malignant Monitoring, Physiologic - methods Neoplasm Invasiveness - pathology Neoplasm Staging oral contraceptives Postpartum Period Pregnancy Pregnancy Complications, Neoplastic - diagnosis Pregnancy Complications, Neoplastic - epidemiology Pregnancy Complications, Neoplastic - therapy Pregnancy Outcome Prenatal Diagnosis Prognosis review Risk Assessment Skin Neoplasms - diagnosis Skin Neoplasms - epidemiology Skin Neoplasms - therapy |
| title | Pregnancy and melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T05%3A52%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pregnancy%20and%20melanoma&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Driscoll,%20Marcia%20S.,%20MD,%20PharmD&rft.date=2016-10-01&rft.volume=75&rft.issue=4&rft.spage=669&rft.epage=678&rft.pages=669-678&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2016.01.061&rft_dat=%3Cproquest_cross%3E1822118775%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1822118775&rft_id=info:pmid/27646737&rft_els_id=S0190962216300391&rfr_iscdi=true |